Literature DB >> 27900888

Using the CRISPR/Cas9 system to eliminate native plasmids of Zymomonas mobilis ZM4.

Qing-Hua Cao1,2, Huan-Huan Shao1,2, Hui Qiu1,2, Tao Li1,2, Yi-Zheng Zhang1,2, Xue-Mei Tan1,2.   

Abstract

The CRISPR/Cas system can be used to simply and efficiently edit the genomes of various species, including animals, plants, and microbes. Zymomonas mobilis ZM4 is a highly efficient, ethanol-producing bacterium that contains five native plasmids. Here, we constructed the pSUZM2a-Cas9 plasmid and a single-guide RNA expression plasmid. The pSUZM2a-Cas9 plasmid was used to express the Cas9 gene cloned from Streptococcus pyogenes CICC 10464. The single-guide RNA expression plasmid pUC-T7sgRNA, with a T7 promoter, can be used for the in vitro synthesis of single-guide RNAs. This system was successfully employed to knockout the upp gene of Escherichia coli and the replicase genes of native Z. mobilis plasmids. This is the first study to apply the CRISPR/Cas9 system of S. pyogenes to eliminate native plasmids in Z. mobilis. It provides a new method for plasmid curing and paves the way for the genomic engineering of Z. mobilis.

Entities:  

Keywords:  CRISPR/Cas9 system; Zymomonas mobilis; expression plasmid; plasmid curing

Mesh:

Substances:

Year:  2016        PMID: 27900888     DOI: 10.1080/09168451.2016.1189312

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  8 in total

1.  Improved high-temperature ethanol production from sweet sorghum juice using Zymomonas mobilis overexpressing groESL genes.

Authors:  Anchittha Kaewchana; Atiya Techaparin; Nongluck Boonchot; Pornthap Thanonkeo; Preekamol Klanrit
Journal:  Appl Microbiol Biotechnol       Date:  2021-11-17       Impact factor: 4.813

2.  A Markerless Method for Genome Engineering in Zymomonas mobilis ZM4.

Authors:  Piyush Behari Lal; Fritz M Wells; Yucai Lyu; Indro N Ghosh; Robert Landick; Patricia J Kiley
Journal:  Front Microbiol       Date:  2019-10-11       Impact factor: 5.640

Review 3.  Targeting Plasmids to Limit Acquisition and Transmission of Antimicrobial Resistance.

Authors:  Corneliu Ovidiu Vrancianu; Laura Ioana Popa; Coralia Bleotu; Mariana Carmen Chifiriuc
Journal:  Front Microbiol       Date:  2020-05-06       Impact factor: 5.640

4.  Characterization and repurposing of the endogenous Type I-F CRISPR-Cas system of Zymomonas mobilis for genome engineering.

Authors:  Yanli Zheng; Jiamei Han; Baiyang Wang; Xiaoyun Hu; Runxia Li; Wei Shen; Xiangdong Ma; Lixin Ma; Li Yi; Shihui Yang; Wenfang Peng
Journal:  Nucleic Acids Res       Date:  2019-12-02       Impact factor: 16.971

5.  Mobility of antimicrobial resistance across serovars and disease presentations in non-typhoidal Salmonella from animals and humans in Vietnam.

Authors:  Samuel Bloomfield; Vu Thuy Duong; Ha Thanh Tuyen; James I Campbell; Nicholas R Thomson; Julian Parkhill; Hoang Le Phuc; Tran Thi Hong Chau; Duncan J Maskell; Gabriel G Perron; Nguyen Minh Ngoc; Lu Lan Vi; Evelien M Adriaenssens; Stephen Baker; Alison E Mather
Journal:  Microb Genom       Date:  2022-05

6.  Function Characterization of Endogenous Plasmids in Cronobacter sakazakii and Identification of p-Coumaric Acid as Plasmid-Curing Agent.

Authors:  Xuemeng Ji; Ping Lu; Yaozhong Hu; Juan Xue; Jing Wu; Bowei Zhang; Yan Zhang; Lu Dong; Huan Lv; Shuo Wang
Journal:  Front Microbiol       Date:  2021-06-25       Impact factor: 5.640

Review 7.  Strategies to combat antimicrobial resistance: anti-plasmid and plasmid curing.

Authors:  Michelle M C Buckner; Maria Laura Ciusa; Laura J V Piddock
Journal:  FEMS Microbiol Rev       Date:  2018-11-01       Impact factor: 16.408

8.  Establishment and application of a CRISPR-Cas12a assisted genome-editing system in Zymomonas mobilis.

Authors:  Wei Shen; Jun Zhang; Binan Geng; Mengyue Qiu; Mimi Hu; Qing Yang; Weiwei Bao; Yubei Xiao; Yanli Zheng; Wenfang Peng; Guimin Zhang; Lixin Ma; Shihui Yang
Journal:  Microb Cell Fact       Date:  2019-10-03       Impact factor: 5.328

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.